Ranibizumab for Neovascular Age-Related Macular Degeneration
Intravitreal administration of ranibizumab for 2 years prevented vision loss and improved mean visual acuity, with low rates of serious adverse events, in patients with minimall...
Publications
5 shownRanibizumab for Treatment of Neovascular Age-Related Macular Degeneration
To assess safety of repeated intravitreal injections of ranibizumab in treating neovascular age-related macular degeneration (AMD), and to assess changes in visual acuity (VA) a...
Maximum Tolerated Dose of a Humanized Anti–Vascular Endothelial Growth Factor Antibody Fragment for Treating Neovascular Age-Related Macular Degeneration
To investigate the maximum tolerated dose of ranibizumab administered as a single intravitreal injection. Open-label, 5-center, uncontrolled, prospective, dose-ranging, interven...
Photodynamic Therapy of Subfoveal Choroidal Neovascularization With Verteporfin
Ophthalmologists should consider interpreting fluorescein angiographic images of subfoveal lesions with terms provided to follow recommendations regarding which patients are mos...
Frequent Co-Authors
Researcher Info
- h-index
- 5
- Publications
- 5
- Citations
- 6,718
- Institution
- University of Miami
External Links
Identifiers
- ORCID
- 0000-0002-4068-6671
Impact Metrics
h-index
5
h-index: Number of publications with at least h citations each.